FIELD: veterinary science; pharmaceutics.
SUBSTANCE: present invention relates to a method of treating diabetes mellitus in an animal of the Canidae family, involving administering a combination of enavogliflozin and insulin.
EFFECT: pharmaceutical combination according to the present invention, containing enavogliflozin as an active ingredient, exhibits an excellent blood glucose control effect and thus can be effectively used for treating diabetes mellitus in an animal of the Canidae family.
7 cl, 10 dwg, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTICONVULSIVE DERIVATIVES APPLIED FOR PREVENTING THE DEVELOPMENT OF DIABETES MELLITUS AND SYNDROME X | 2001 |
|
RU2268720C2 |
| METHOD OF TREATING HYPERGLYCAEMIA | 2017 |
|
RU2739255C2 |
| AGENT FOR TREATMENT OF PATIENT WITH DIABETES MELLITUS | 1996 |
|
RU2139718C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING METABOLIC SYNDROME | 2011 |
|
RU2593960C2 |
| MATERIALS AND METHODS FOR METABOLISM MODULATION | 2005 |
|
RU2387445C2 |
| COMPOSITIONS AND METHODS FOR TREATING DIABETES | 2004 |
|
RU2367423C2 |
| METHOD OF WEIGHT REDUCTION | 2013 |
|
RU2664442C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING METABOLIC SYNDROME | 2011 |
|
RU2732703C2 |
| METHOD OF TREATING METABOLIC SYNDROME WITH USING DOPAMINE RECEPTOR AGONISTS | 2008 |
|
RU2473344C2 |
| METHOD OF IMPROVEMENT OF LIVER FUNCTION | 2013 |
|
RU2653478C2 |
